Microtissues®

Summary

Published in Journal of Nanobiotechnology (2026), this peer-reviewed study used 3D Petri Dish® micro-molds to form scaffold-free 3D microtissues. Full citation: Bravo, Maria, et al. Beyond one-size-fits-all: cancer biology shapes nanoparticle behavior

🧬 Oncology

Beyond one-size-fits-all: cancer biology shapes nanoparticle behavior

Journal of Nanobiotechnology 2026 Bravo, Maria, et al
Cite as: Bravo, Maria, et al. Beyond one-size-fits-all: cancer biology shapes nanoparticle behavior. Journal of Nanobiotechnology (2026). doi:10.1186/s12951-026-04395-1 doi.org/10.1186/s12951-026-04395-1

Research Overview

Nanoparticles are a promising cancer therapy that rarely reaches the clinic, and this study argues the pipeline is looking in the wrong place — optimizing particle physics while ignoring how tumor biology governs particle behavior. Polyethyleneimine-functionalized, silica-coated gold nanoparticles were tested in 3D spheroids from four cancer models representing lung, colon, breast, and cervical cancer.

Accumulation and penetration differed sharply between models, with an inverse relationship: spheroids that internalized particles more slowly allowed deeper diffusion. Proteomics traced the variability to tumor-specific expression of endocytic and extracellular-matrix proteins — evidence that nanoparticle design should account for the target tumor’s biology rather than assume one formulation fits all.

Key Discoveries

  • Au@mSi-PEI nanoparticles showed distinct uptake and penetration across lung, colon, breast, and cervical spheroid models
  • Inverse relationship: slower internalization allowed deeper diffusion into the spheroid
  • Tumor-specific endocytic and ECM protein expression explained the variability